Asia'a largest vaccine event
Patrick Bergstedt was appointed President, Asia Pacific for MSD in September 2011, based in Singapore. He has a proven commercial track record in pharmaceuticals, medical devices, and biologics. His working career spans a number of geographies including South Africa, F…more ›
Labeeb M. Abboud is Senior Vice President and General Counsel of the International AIDS Vaccine Initiative, a non-profit organization whose mission is to ensure the development of safe, effective, accessible, preventive HIV vaccines for use throughout the world. IAVI’s…more ›
Dr.Suresh Jadhav, M.Pharm., Ph.D. is the Executive Director of Serum Institute of India Ltd., one of the largest vaccine manufacturers from the developing countries, supplying vaccines to more than 140 countries through U.N. Agencies at affordable prices. Dr. Jadhav al…more ›
Join the industry's elite
In its 6th consecutive year, World Vaccine Congress Asia has rapidly developed to become the central meeting point for Asia's vaccine industry and international leaders. The congress brings together all the major vaccine stakeholders, through pharmas, biotechs, NGOs, research institutes, regulators and CDCs to discuss latest industry trends, business strategies and scientific developments in the global and Asian vaccine markets.
In 2012, we bring you 3 conferences for the price of 1!
- World Vaccine Partnering Congress
- World Vaccine Trials Congress
- World Vaccine Manufacturing Congress
Sponsors
Come to World Vaccine Congress Asia 2012 and learn how to:
- Gain market access and penetrate into emerging markets
- Enhance manufacturing capabilities
- Create strategic partnerships with clinical outsourcing organizations for operations in Asia
- Collaborate with Asian biotechs in various stages in their vaccine development
- Forge successful partnerships for vaccine co-development of tropical or Asian diseases
You’ll come away with great new ideas to do better business
World Vaccine Congress Asia 2012 will focus on:
- Public healthcare reform, legislation & immunisation
- Setting priorities in the national vaccine plan
- Meeting the needs of global emerging markets
- Global market access strategies
- Developing influenza vaccines business for Asia
- R&D, partnership & investments
- Strategies for Asia pandemic & infectious disease preparedness
If you need to know the latest innovations in these areas you must attend.
World class vaccine solution providers attend to:
- Get their brand in front of senior decision makers across Asia?
- Position themselves as an industry leader
- Create sales leads and deliver a return on investment
- Break into the lucrative vaccine market in Asia
- Network with senior level decision makers in the region
This is the single most important marketing and business development event you can attend this year.
5 Reasons to attend
- 500+ senior vaccines executives all with decision making capacities on their organisation, product or business unit
- 100+ C-level and VP speakers across strategic, R&D, clinical, manufacturing and cell culture disciplines
- 40+research /academic poster sessions in a dedicated forum
- 4 conferences representing the complete vaccine value chain in one place
What sets World Vaccine Congress Asia apart:
- Real peer to peer intelligence: an 85% governmental, pharma and biotech speaker faculty delivers on content
- Quality and quantity: over 100 keynotes, case studies, panels and streams offering a comprehensive programme to match your business needs
- Meet active decision makers: congress attendees are vetted on their responsibilities to managing manufacturing campaigns, brands, business units and pipelines
- A truly global gathering: all major regions and continents represented with over 30 countries in attendance
- 20hrs of immersive social events: have the means to network with the industry’s elite
Limited speaking opportunities available for leading solution providers
Advancing vaccine clinical development in Asia for pharmas, biotechs and partners
Advance your clinical trials effectively and efficiently and overcome the biggest hurdle to placing your vaccine candidate on the market.
Learn how to:
- Leverage on Asia’s clinical research capabilities to reduce R&D cost for vaccines
- Access a wider patient pool in Asia for trials for both adult and pediatric vaccines
- Navigate around regulatory complexities in conducting vaccine clinical trials in Asia
- Develop successful strategies in conducting vaccine clinical trial that are cost effectively and efficiently in Asia
- Identify and meet suitable CROs and other partners that have specialty in handling vaccines
- Identify the most suitable site locations to conduct vaccine trials in Asia
You’ll come away with great new ideas to do better business.
Adopt production capabilities and establish robust and efficient manufacturing processes for vaccine development and manufacturing advances.
Learn how to:
- Reduce Drug manufacturing cost for vaccines
- Outsource vaccine manufacturing but maintaining quality
- Find the right partners either globally or in Asia that meets their needs and standards
- Ensure intellectual property protection while outsourcing to third parties
- Ensure regulatory compliance for Asia markets and to address the global concerns on quality, reliability and authenticity
- Ensure manufacturing plants receive Asian regulatory approval for exports
- Integrate the latest and advanced technological solutions
- Increase competitive edge against competition
- Expand their business internationally to cover the international market
- Increase customer base
- Meet potential partners
You’ll come away with great new ideas to do better business.
Advance vaccine development effectively with innovation, partnering and discovery opportunities.
Learn how to:
- Scout for potential biotechs or pharmas to acquire or collaborate with
- Establish industry leadership and strengthen branding in the region
- Educate and attract the industry on how you could possibly work with them through collaboration, licensing or M&A
- Source for funding from pharmas and investors
- Develop a successful strategy for pipelines from R&D to commercialization
- Find partners to accelerate commercialization
- Find biotechs or pharmas with highest ROIs
- Manage risks in investing in start-ups to mid size companies
Come away with new ideas and new strategies to do better business.
